metastatic colorectal cancer (crc)
Showing 1 - 2 of 2
Metastatic Colorectal Cancer (CRC) Trial (TRS003, China-approved Bevacizumab, mFOLFOX6)
Not yet recruiting
- Metastatic Colorectal Cancer (CRC)
- TRS003
- +2 more
- (no location specified)
May 12, 2022
Metastatic Colorectal Cancer (CRC) Trial in Shanghai (BI 1701963, Camptosar®)
Terminated
- Metastatic Colorectal Cancer (CRC)
- BI 1701963
- Camptosar®
-
Shanghai, ChinaShanghai East Hospital, Tongji University China
Apr 19, 2022